scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00520-014-2225-0 |
P698 | PubMed publication ID | 24682581 |
P2093 | author name string | Michael Koldehoff | |
Susanne Koeppen | |||
Abhiyrahmi Thirugnanasambanthan | |||
P2860 | cites work | Graft-versus-host disease: why have we not made more progress? | Q27012940 |
Increased incidence of neurological complications in patients receiving an allogenic bone marrow transplantation from alternative donors. | Q33179317 | ||
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report | Q34474243 | ||
Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation. | Q34963618 | ||
Polymyositis as a manifestation of chronic graft-versus-host disease | Q35037606 | ||
Polymyositis complicating donor lymphocyte infusion after stem cell transplantation for relapsed chronic myeloid leukemia: report of a case and review of literature | Q36579562 | ||
Polymyositis after donor lymphocyte infusion. | Q40277132 | ||
Polymyositis and myocarditis after donor lymphocyte infusion | Q40388761 | ||
Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature | Q41474842 | ||
Peripheral neuropathy after bone marrow transplantation | Q41635311 | ||
Graft-versus-host disease-related polymyositis | Q43195998 | ||
Prospective evaluation of neurological complications after allogeneic bone marrow transplantation | Q43994969 | ||
Myasthenia gravis after allogeneic bone marrow transplantation treated with mycophenolate mofetil monitored by peripheral blood OX40+ CD4+ T cells. | Q44235080 | ||
Life-threatening neurological complications after bone marrow transplantation in children | Q45143160 | ||
Acute polymyositis after donor lymphocyte infusion | Q45227575 | ||
Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease. | Q48401354 | ||
Neurological complications of hematopoietic stem cell transplantation (HSCT): a retrospective study in a HSCT center in Brazil | Q48867436 | ||
Acute neuropathies after peripheral blood stem cell and bone marrow transplantation | Q60976781 | ||
Myasthenia gravis after allogeneic bone marrow transplantation for lymphoblastic lymphoma | Q73338182 | ||
Chronic demyelinating polyneuropathy in graft-versus-host disease following allogeneic bone marrow transplantation | Q74176571 | ||
Early neurologic complications following allogeneic bone marrow transplant for leukemia: a prospective study | Q74575128 | ||
Myasthenia gravis and polymyositis as manifestations of chronic graft-versus-host-disease | Q74664210 | ||
Correlation of peripheral blood OX40+(CD134+) T cells with chronic graft-versus-host disease in patients who underwent allogeneic hematopoietic stem cell transplantation | Q77136492 | ||
Steroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapy | Q79836234 | ||
Occurrence of autoantibodies in chronic graft vs. host disease after allogeneic stem cell transplantation | Q80945824 | ||
Dermatomyositis-like muscle pathology in patients with chronic graft-versus-host disease | Q84384688 | ||
P433 | issue | 9 | |
P304 | page(s) | 2337-2341 | |
P577 | publication date | 2014-03-29 | |
P1433 | published in | Supportive Care in Cancer | Q15766919 |
P1476 | title | Neuromuscular complications after hematopoietic stem cell transplantation | |
P478 | volume | 22 |
Q92619758 | Chronic Graft-Versus-Host-Disease-Related Polymyositis: a 17-Months-Old Child with a Rare and Late Complication of Haematopoietic Stem Cell Transplantation |
Q52974741 | High prevalence of small- and large-fiber neuropathy in a prospective cohort of patients with moderate to severe chronic GvHD. |
Q90326304 | Neurologic complications after allogeneic transplantation: a meta-analysis |
Q33913077 | Progressive hypoventilation due to mixed CD8+ and CD4+ lymphocytic polymyositis following tremelimumab - durvalumab treatment |
Q53737471 | [Paraplegia after hematopoietic stem cell transplantation]. |